CAMP4 Therapeutics Insider Trades
NASDAQ: CAMPHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 5 · $99.05K
- Sales
- 6 · $2.50M
- Shares bought / sold
- 46.03K / 593.61K
- Net activity
- Net selling $2.4 million
CAMP4 Therapeutics insider activity
Over the last 12 months, CAMP4 Therapeutics insiders reported 11 transactions on SEC Form 4: 5 open-market purchases and 6 sales. Insiders bought $99,051 and sold $2.5 million worth of stock, for net insider selling of $2.4 million. The largest seller was Schwab Andrew J., with $2.5 million in reported sales.
The most recent filing shows Gold Kelly (Chief Financial Officer) buying 10,000 shares at $3.96 on Aug 31, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put CAMP's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
CAMP insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Aug 31, 2026 | Gold KellyChief Financial Officer | Buy | 10,000 | $39.60K | Form 4 |
| Aug 27, 2026 | Schwab Andrew J.Director | Sale | 400,000 | $1.62M | Form 4 |
| Aug 24, 2026 | Schwab Andrew J.Director | Sale | 10 | $45 | Form 4 |
| Aug 21, 2026 | Schwab Andrew J.Director | Sale | 32,018 | $144.08K | Form 4 |
| Aug 20, 2026 | Schwab Andrew J.Director | Sale | 114,700 | $520.74K | Form 4 |
| Aug 19, 2026 | Tardiff DanielChief Scientific Officer | Sale | 1,738 | $8.27K | Form 4 |
| Aug 19, 2026 | Schwab Andrew J.Director | Sale | 45,147 | $214.90K | Form 4 |
| Aug 3, 2026 | Gold KellyChief Financial Officer | Buy | 6,551 | $10.81K | Form 4 |
| Aug 3, 2026 | Maricich YuriChief Medical Officer | Buy | 6,551 | $10.81K | Form 4 |
| Aug 3, 2026 | Mandel-Brehm JoshChief Executive Officer | Buy | 6,551 | $10.81K | Form 4 |
| Aug 3, 2026 | Young Richard ADirector | Buy | 16,378 | $27.02K | Form 4 |
| Sep 11, 2025 | Young Richard ADirector | Buy | 15,151 | $25.00K | Form 4 |
| Sep 11, 2025 | Maricich YuriChief Medical Officer | Buy | 6,060 | $10.00K | Form 4 |
| Sep 11, 2025 | Nashat AmirDirector | Buy | 85,468 | $130.77K | Form 4 |
| Sep 11, 2025 | Nashat AmirDirector | Buy | 1,221,721 | $1.87M | Form 4 |
| Sep 11, 2025 | Polaris Management Co. VII, L.L.C. & Polaris Partners VII, L.P. & Polaris Entrepreneurs' Fund VII, L.P. & Polaris Partners X, L.P. & Polaris Partners GP X, L.L.C. & SCHULMAN AMY W & Chee Brian10% Owner | Buy | 85,468 | $130.77K | Form 4 |
| Sep 11, 2025 | Polaris Management Co. VII, L.L.C. & Polaris Partners VII, L.P. & Polaris Entrepreneurs' Fund VII, L.P. & Polaris Partners X, L.P. & Polaris Partners GP X, L.L.C. & SCHULMAN AMY W & Chee Brian10% Owner | Buy | 1,221,721 | $1.87M | Form 4 |
| Sep 11, 2025 | Mandel-Brehm JoshChief Executive Officer | Buy | 6,060 | $10.00K | Form 4 |
| Sep 11, 2025 | Gold KellyChief Financial Officer | Buy | 6,060 | $10.00K | Form 4 |
| Sep 11, 2025 | 5AM Partners VI, LLC & 5AM Ventures VI, L.P. & 5AM Opportunities II (GP), LLC & 5AM Opportunities II, L.P. & 5AM Partners VII, LLC & 5AM Ventures VII, L.P. & PARMAR KUSH10% Owner | Buy | 2,941,176 | $4.50M | Form 4 |
| Sep 11, 2025 | Schwab Andrew J.Director | Award | 2,941,176 | $4.50M | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4